AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mbgron 25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Care Formulation Labs Pvt Ltd

Salt Composition

Mirabegron (25mg)

Overview Mbgron 25 Tablet ER

Myrtlex 25 Extended-Release Tablets alleviate overactive bladder symptoms such as heightened urinary frequency, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always adhere to your physician's prescribed dosage and duration. Myrtlex 25 ER tablets may be taken with or without food; swallow whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms, so consult your doctor before stopping. Complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infection, tachycardia, and arthralgia. Report any bothersome or persistent side effects to your doctor immediately. Prior to treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment should exercise caution, undergoing regular monitoring as directed by their doctor.

Uses of Mbgron 25 Tablet ER

Managing symptoms associated with overactive bladder

Major Benefits of Mbgron 25 Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Mbgron 25 Tablet ER can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Mbgron 25 Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Mbgron 25 Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mbgron 25 Extended-Release Tablet can be consumed with or without food, although consistent timing is recommended.

How Mbgron 25 Tablet ER works:

Mbgron 25 Extended-Release Tablets contain a beta-3 adrenergic agonist. This medication acts by stimulating bladder beta-3 receptors, leading to relaxation of the bladder musculature. The result is a reduction in urinary urgency, frequency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Mbgron 25 Tablet ER concurrently with alcohol. Physician consultation is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Mbgron 25mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Mbgron 25 mg tablets are likely not safe for breastfeeding mothers. Studies in humans indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Mbgron 25 Tablet ER.

KidneyKidneyCAUTION

Use of Mbgron 25 Extended-Release tablets requires careful consideration in individuals with advanced kidney impairment. Dosage modification of Mbgron 25 Extended-Release tablets might be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Mbgron 25 Tablet ER cautiously, potentially requiring dose modification. Physician consultation is advised. Mbgron 25 Tablet ER is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Mbgron 25 Tablet ER :

Should you forget a dose of Mbgron 25 Tablet ER, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Mbgron 25 Tablet ER

LabelValue
Chemical Type Anilide-based compound
Developing Habits No.
Treatment Category Urological Care
Actions Beta-3 agonist for bladder control

FAQs on Mbgron 25 Tablet ER

The full effects of Mbgron 25 Tablet ER may become apparent after eight weeks or more of treatment. Dosage adjustments may be considered after four to eight weeks, depending on individual response.
Continue taking Mbgron 25 Tablet ER, even if your symptoms improve. This medication treats overactive bladder symptoms—urgency, frequency, and incontinence—but doesn't cure the condition. Discontinuing treatment may cause symptoms to return.
Mbgron 25 Tablet ER shouldn't interfere with your sleep. Consult your doctor about any sleep difficulties.
Mbgron 25 Tablet ER should not be given to children under 18 due to a lack of studied effectiveness and safety data in this age group.
No, consistent daily use, as prescribed, is crucial. This medication manages your condition, not curing it. Intermittent use prevents your bladder from adapting fully, leading to ineffective treatment and symptom recurrence.
Mbgron 25 Tablet ER may cause urinary tract infections (kidneys, ureters, bladder, or urethra), though this is not universal. Renal stones and bladder pain have been rarely reported. Patients with impaired kidney function should use caution and promptly report any kidney-related adverse effects to their physician.
Caution is advised when taking Mbgron 25 Tablet ER if you have high blood pressure. Regular blood pressure monitoring is recommended, as this medication may elevate blood pressure in some individuals. It's contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help, regardless of symptoms. Mbgron 25 Tablet ER overdose can elevate heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Mbgron 25 Tablet ER
160
MRP 195
17% off